Lipid substitution of mitochondrial monoamine oxidase can lead to the abolition of clorgyline selective inhibition without alteration in the A/B ratio assessed by substrate utilisation.
D000818:Animals; D003010:Clorgyline / Q000494:pharmacology*; D004134:Dimyristoylphosphatidylcholine; D008297:Male; D008563:Membrane Lipids / Q000378:metabolism*; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000378:metabolism*; D010627:Phenethylamines / Q000378:metabolism; D010713:Phosphatidylcholines; D011437:Propylamines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013379:Substrate Specificity
D008563:Membrane Lipids; D010627:Phenethylamines; D010713:Phosphatidylcholines; D011437:Propylamines; D012701:Serotonin; D008995:Monoamine Oxidase; D003010:Clorgyline; D004134:Dimyristoylphosphatidylcholine